521 related articles for article (PubMed ID: 20637199)
1. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
[TBL] [Abstract][Full Text] [Related]
2. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
[TBL] [Abstract][Full Text] [Related]
3. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
Plantinga TS; Crisan TO; Oosting M; van de Veerdonk FL; de Jong DJ; Philpott DJ; van der Meer JW; Girardin SE; Joosten LA; Netea MG
Gut; 2011 Sep; 60(9):1229-35. PubMed ID: 21406388
[TBL] [Abstract][Full Text] [Related]
4. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
[TBL] [Abstract][Full Text] [Related]
5. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner.
Sorbara MT; Ellison LK; Ramjeet M; Travassos LH; Jones NL; Girardin SE; Philpott DJ
Immunity; 2013 Nov; 39(5):858-73. PubMed ID: 24238340
[TBL] [Abstract][Full Text] [Related]
6. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
[TBL] [Abstract][Full Text] [Related]
7. ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn's disease patients.
Wolfkamp SC; Verseyden C; Vogels EW; Meisner S; Boonstra K; Peters CP; Stokkers PC; te Velde AA
World J Gastroenterol; 2014 Mar; 20(10):2664-72. PubMed ID: 24627602
[TBL] [Abstract][Full Text] [Related]
8. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.
Cooney R; Baker J; Brain O; Danis B; Pichulik T; Allan P; Ferguson DJ; Campbell BJ; Jewell D; Simmons A
Nat Med; 2010 Jan; 16(1):90-7. PubMed ID: 19966812
[TBL] [Abstract][Full Text] [Related]
9. Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
Grant SF; Baldassano RN; Hakonarson H
Expert Rev Mol Diagn; 2008 Mar; 8(2):199-207. PubMed ID: 18366306
[TBL] [Abstract][Full Text] [Related]
10. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
11. Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal Homeostasis.
Zhang H; Zheng L; McGovern DP; Hamill AM; Ichikawa R; Kanazawa Y; Luu J; Kumagai K; Cilluffo M; Fukata M; Targan SR; Underhill DM; Zhang X; Shih DQ
J Immunol; 2017 Mar; 198(5):2133-2146. PubMed ID: 28130498
[TBL] [Abstract][Full Text] [Related]
12. Autophagy and Crohn's disease.
Nguyen HT; Lapaquette P; Bringer MA; Darfeuille-Michaud A
J Innate Immun; 2013; 5(5):434-43. PubMed ID: 23328432
[TBL] [Abstract][Full Text] [Related]
13. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.
Prescott NJ; Fisher SA; Franke A; Hampe J; Onnie CM; Soars D; Bagnall R; Mirza MM; Sanderson J; Forbes A; Mansfield JC; Lewis CM; Schreiber S; Mathew CG
Gastroenterology; 2007 May; 132(5):1665-71. PubMed ID: 17484864
[TBL] [Abstract][Full Text] [Related]
14. Evidence of expression variation and allelic imbalance in Crohn's disease susceptibility genes NOD2 and ATG16L1 in human dendritic cells.
Hu J; Peter I
Gene; 2013 Sep; 527(2):496-502. PubMed ID: 23850724
[TBL] [Abstract][Full Text] [Related]
15. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
16. NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease.
Glubb DM; Gearry RB; Barclay ML; Roberts RL; Pearson J; Keenan JI; McKenzie J; Bentley RW
World J Gastroenterol; 2011 Jun; 17(23):2829-37. PubMed ID: 21734790
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
[TBL] [Abstract][Full Text] [Related]
18. ATG16L1: A multifunctional susceptibility factor in Crohn disease.
Salem M; Ammitzboell M; Nys K; Seidelin JB; Nielsen OH
Autophagy; 2015 Apr; 11(4):585-94. PubMed ID: 25906181
[TBL] [Abstract][Full Text] [Related]
19. The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
Stevens C; Henderson P; Nimmo ER; Soares DC; Dogan B; Simpson KW; Barrett JC; ; Wilson DC; Satsangi J
Gut; 2013 May; 62(5):695-707. PubMed ID: 22684479
[TBL] [Abstract][Full Text] [Related]
20. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
